Viewing Study NCT01597492


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2026-01-09 @ 3:39 AM
Study NCT ID: NCT01597492
Status: COMPLETED
Last Update Posted: 2018-08-16
First Post: 2012-05-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Sponsor: Human Genome Sciences Inc., a GSK Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-05-31
Start Date Type: ACTUAL
Primary Completion Date: 2015-09-01
Primary Completion Date Type: ACTUAL
Completion Date: 2015-09-24
Completion Date Type: ACTUAL
First Submit Date: 2012-05-08
First Submit QC Date: None
Study First Post Date: 2012-05-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-04-28
Results First Submit QC Date: None
Results First Post Date: 2016-07-25
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-20
Last Update Post Date: 2018-08-16
Last Update Post Date Type: ACTUAL